We’re unlocking 1+ million COVID-19 testing capacity per day

BillionToOne developed a groundbreaking RNA-extraction free COVID-19 test assay that is much higher throughput than existing qPCR methods and is highly accurate.

Combining the unused Sanger sequencer capacity from the Human Genome project and the proprietary machine learning algorithm, BillionToOne’s COVID testing protocol removes the costly and time-consuming step of RNA extraction and has the potential to unlock millions in daily testing capacity worldwide.